Index by author

October 01, 2015; Volume 82,Issue 10

  1. Starling, Randall C.

    1. Sacubitril-valsartan and the evolution of heart failure care
      Randall C. Starling, MD, MPH, FACC, FESC
      Cleveland Clinic Journal of Medicine October 2015, 82 (10) 702-704; DOI: https://doi.org/10.3949/ccjm.82a.15121

      It was hard to believe that any new additional therapy would make a significant difference.

  2. Taylor, David O.

    1. A new class of drugs for systolic heart failure: The PARADIGM-HF study
      A new class of drugs for systolic heart failure: The PARADIGM-HF study
      Marwa A. Sabe, MD, MPH, Miriam S. Jacob, MD and David O. Taylor, MD
      Cleveland Clinic Journal of Medicine October 2015, 82 (10) 693-701; DOI: https://doi.org/10.3949/ccjm.82a.14163

      Valsartan-sacubitril is the first new drug in over a decade to decrease death rates in patients with systolic heart failure.

  3. Thiruchelvam, Nirosshan

    1. Upper-limb deep vein thrombosis in Paget-Schroetter syndrome
      Nirosshan Thiruchelvam, MD, Farayi Mbuvah, MD, Gaurav Kistangari, MD, MPH and Anil Kumar Reddy Anumandla, MD
      Cleveland Clinic Journal of Medicine October 2015, 82 (10) 658-659; DOI: https://doi.org/10.3949/ccjm.82a.14115

      A weight lifter with no medical history presented with pain and swelling in his left arm.

  4. Weiss, Daniel

    1. Starting insulin therapy (August 2015)
      Daniel Weiss, MD
      Cleveland Clinic Journal of Medicine October 2015, 82 (10) 638; DOI: https://doi.org/10.3949/ccjm.82c.10001

      Readers comment on resuming anticoagulation after hemorrhage (April 2015) and on starting insulin therapy in patients with type 2 diabetes (August 2015).

« Previous (Pages : 1 2 3 4 ... 4)next »
Back to top

In this issue